PharmaCyte Biotech Inc (PMCB)

[1234jklm]

The good thing about the pr today is it’s openness and honesty. No spin.

We just want to know what’s going on with our investment.

Clearly. Fully. Consistently.

I would like to know what’s happening with Mellingen cells development. Ascites development, the Asian plan and diabetes clinical trials.

Even if they’re still happening.

That’s why the failure to hold the agreed quarterly update is such a failure of management. It’s sows doubt and mistrust. It is fair to then distrust and criticize the ceo and he must take responsibility for that. It’s not just about patience.its about managerial responsibility. That’s why releases full of spin which say nothing precisely are not good communication and why the last press release about advances and optimisation was very poor and created such push back.

Releasing a drop of good information today doesn’t exonerate the ceo imho.

The company communication has been at fault and the failure to hold the agreed quarterly updates has put the ceo in a very poor light imho. It makes us question his honesty and reliability and that’s not good for him or our company. And it allows his detractors and defamers to gain ground.